arrow
H

Hugh Mostafid

Royal Surrey County Hospital
H指数:39
被引数:9,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes of Intermediate Risk Non–muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials

对接受辅助治疗的中危非肌层浸润性膀胱癌结局的汇总分析:四项随机对照试验的合并分析

2026-07-140
PRE
Active surveillance in low-grade NMIBC — results of an international two-round modified Delphi consensus

低级别非肌层浸润性膀胱癌中的主动监测——国际两轮改良德尔菲共识的结果

2026-04-010
PRE
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer

关于为原发性中危非肌肉浸润性膀胱癌患者定义随访策略的研究

2025-05-210
PRE
Unmet Need in Non-muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Costeffectiveness Analyses from the International Bladder Cancer Group

非肌层浸润性膀胱癌对卡介苗治疗无效后的未满足需求:国际膀胱癌小组的系统评价和成本效益分析

2025-02-010
OAAI
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels

膀胱癌根治性膀胱切除术后随访的一致性:基于欧洲泌尿外科学会膀胱癌指南专家组协作开发专家实践框架

2025-02-012
PRE
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

欧洲泌尿外科协会上尿路尿路上皮癌指南: 2023更新

2023-07-01212
OA
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members
2023-06-014
OAAI
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum

非肌层浸润性频谱中原发性乳头状Ta 3级膀胱癌的预后

2023-04-0110
OA
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum
2022-11-014
PRE
Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT
2022-10-0115
OA
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

欧洲泌尿外科协会非肌层浸润性膀胱癌指南 (Ta、T1和原位癌)

2022-01-01781
PRE
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study

WHO1973和WHO2004/2016分级系统对原发性Ta/T1非肌层浸润性膀胱癌的预后价值: 欧洲泌尿外科协会非肌层浸润性膀胱癌指南的多中心小组研究

2021-04-0165
PREAI
An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting

关于膀胱肿瘤整体切除术的国际合作共识声明,包括两项系统评价,两轮Delphi调查和共识会议

2020-10-0193
OAAI